ARRB2 levels is a potential biomarker for depression and Alzheimer’s disease (Avissar et al., 2004; Golan et al., 2013; Mendez-David et al., 2013; Thathiah et al., 2013; Petit et al., 2018). This evidence concerns the gene ARRB2 and early-onset autosomal dominant Alzheimer disease.